Molecular Network Analysis of Endometriosis Reveals a Role for c-Jun–Regulated Macrophage Activation

Michael T Beste,Nicole Pfäffle-Doyle,Emily A. Prentice,S. Morris,D. Lauffenburger,K. Isaacson,L. Griffith

DOI: https://doi.org/10.1126/scitranslmed.3007988

IF: 17.1

2014-02-01

Science Translational Medicine

Abstract:The molecular correlates of heterogeneous endometriosis symptoms support a role for innate inflammatory responses converging upon c-Jun and NFκB signaling cascades. Endometriosis: Embracing Complexity Despite its widespread contribution to infertility and debilitating pelvic pain, treatments for endometriosis—an invasive displacement of endometrial tissue outside the uterus—primarily address symptoms and fall short on combating the underlying disease. Avenues for targeted intervention have been lacking, in part due to significant patient heterogeneity that hampers reproducible findings across diverse study populations. To overcome this hurdle, Beste et al. have applied a data-driven strategy to uncover the natural variation in pelvic inflammatory status across a broad cohort of endometriosis patients. By naïvely characterizing comprehensive molecular profiles for each patient, the authors were able to identify a coherent signature of macrophage activity that was otherwise obscured by conventional staging criteria. Further experiments on isolated macrophages revealed a refined signature that unexpectedly implicated the c-Jun N-terminal kinase (JNK) signaling pathway. By confirming that small-molecule inhibition of JNK signaling broadly curbed macrophage inflammatory activity, this work provides a possible lead for future experimental and clinical studies into curtailing the deleterious inflammatory response to endometriotic lesions. If this general approach is validated in larger populations, such profiles may also be helpful as a complementary tool to better identify patients at greater risk for recurrence who would benefit from aggressive treatment. Clinical management of endometriosis is limited by the complex relationship between symptom severity, heterogeneous surgical presentation, and variability in clinical outcomes. As a complement to visual classification schemes, molecular profiles of disease activity may improve risk stratification to better inform treatment decisions and identify new approaches to targeted treatment. We use a network analysis of information flow within and between inflammatory cells to discern consensus behaviors characterizing patient subpopulations. Unsupervised multivariate analysis of cytokine profiles quantified by multiplex immunoassays identified a subset of patients with a shared “consensus signature” of 13 elevated cytokines that was associated with common clinical features of endometriosis, but was not observed among patient subpopulations defined by morphologic presentation alone. Enrichment analysis of consensus markers reinforced the primacy of peritoneal macrophage infiltration and activation, which was demonstrably elevated in ex vivo cultures. Although familiar targets of the nuclear factor κB family emerged among overrepresented transcriptional binding sites for consensus markers, our analysis provides evidence for an unexpected contribution from c-Jun, c-Fos, and AP-1 effectors of mitogen-associated kinase signaling. Their crucial involvement in propagation of macrophage-driven inflammatory networks was confirmed via targeted inhibition of upstream kinases. Collectively, these analyses suggest a clinically relevant inflammatory network that may serve as an objective measure for guiding treatment decisions for endometriosis management, and in the future may provide a mechanistic endpoint for assessing efficacy of new agents aimed at curtailing inflammatory mechanisms that drive disease progression.